Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a common leaf lower blood sugar?

NCT ID NCT07833397

NEW Disease control Sponsor: Maranatha Christian University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 22, 2026 · Last updated Sep 22, 2026

Summary

Researchers are testing whether daily capsules of moringa oleifera leaf powder can lower fasting blood glucose in adults aged 25 to 55 with prediabetes. Half of the 114 participants receive moringa capsules and half receive placebo capsules for 90 days. Everyone checks their fasting blood glucose every three days and reports any side effects. The trial aims to see if moringa makes a difference compared with placebo.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Moringa oleifera leaf powder in capsules
What this could lead to
If it works, moringa leaf powder could offer a low-cost, plant-based way to help people with prediabetes keep their blood sugar in check.
What could go wrong
This is an early, single-center study of 114 people, so any benefit may be small or may not hold up in larger trials. Moringa can also cause stomach upset or interact with other medicines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

114 people

The number who actually took part.

Started

Apr 2024

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Fasting blood glucose levels of 100-125 mg/dL * Who had not received oral antidiabetic medications or insulin within the previous three months * Had provided written informed consent Exclusion Criteria: * Individuals with hypertension or other significant comorbid medical conditions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prediabetes are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glucose intolerance Insulin Resistance prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prediabetes Prediabetes (insulin resistance, impaired glucose tolerance)

Contacts and locations

Locations

  • Byuderma Clinic

    Bekasi, West Java, 17131, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.